MITOXANTRONE SANDOZ Olaszország - olasz - AIFA (Agenzia Italiana del Farmaco)

mitoxantrone sandoz

sandoz s.p.a. - mitoxantrone - mitoxantrone

MITOXANTRONE ACCORD Olaszország - olasz - AIFA (Agenzia Italiana del Farmaco)

mitoxantrone accord

accord healthcare, s.l.u. - mitoxantrone - mitoxantrone

MITOXANTRONE Olaszország - olasz - AIFA (Agenzia Italiana del Farmaco)

mitoxantrone

crinos s.p.a. - mitoxantrone - mitoxantrone

MITOXANTRONE BIOPROGRESS Olaszország - olasz - AIFA (Agenzia Italiana del Farmaco)

mitoxantrone bioprogress

bioprogress s.p.a. - mitoxantrone - mitoxantrone

MITOXANTRONE SALUS Olaszország - olasz - AIFA (Agenzia Italiana del Farmaco)

mitoxantrone salus

salus researches s.p.a. - mitoxantrone - mitoxantrone

MITOXANTRONE MYLAN Olaszország - olasz - AIFA (Agenzia Italiana del Farmaco)

mitoxantrone mylan

mylan s.p.a. - mitoxantrone - mitoxantrone

MITOXANTRONE CRIN EV 20MG 10ML Olaszország - olasz - AIFA (Agenzia Italiana del Farmaco)

mitoxantrone crin ev 20mg 10ml

crinos spa - mitoxantrone cloridrato - preparazione iniettabile - "20 mg/10 ml soluzione iniettabile uso endovenoso" 1 flaconcino 10 ml

NOVANTRONE Olaszország - olasz - AIFA (Agenzia Italiana del Farmaco)

novantrone

meda pharma s.p.a. - mitoxantrone - mitoxantrone

ONKOTRONE Olaszország - olasz - AIFA (Agenzia Italiana del Farmaco)

onkotrone

baxter s.p.a. - mitoxantrone - mitoxantrone

Tabrecta Európai Unió - olasz - EMA (European Medicines Agency)

tabrecta

novartis europharm limited  - capmatinib dihydrochloride monohydrate - carcinoma, polmone non a piccole cellule - agenti antineoplastici - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.